Ecommerce ordering is currently available for USA customers. International customers should contact their sales representative for orders.
Disclaimer: The kit labels displayed in each photo on this website do not necessarily represent the regulatory status of each product for every country of our customers.

COVID-19 Ag / Influenza A+B Ag

  • Bio-Type Nasopharyngeal Swab
  • Method Rapid Test
  • CE Y
  • # of Tests 20 test swab
  • Sensitivity 96.4% COVID / 94.1% FLU A / 91.7% FLU B
  • Sample Volume Nasopharyngeal Swab
  • Incubation Time(s) 15 min
  • Storage Conditions 2° C-30° C
  • SKU:  RAP6172
Approximate Lead Time 1 - 2 Weeks
For Bulk Orders of 35+ Kits, please Contact Us

Description:

The COVID-19 Ag Rapid Test (Nasopharyngeal Swab) is a qualitative membrane-based immunoassay for the detection of SARS-CoV-2 Antigens in human nasopharyngeal swab specimen.

SARS-CoV-2 antibody is coated in the test line region. During testing, the specimen reacts with SARS-CoV-2 antibody-coated particles in the test. The mixture then migrates upward on the membrane by capillary action and reacts with the SARS-CoV-2 antibody in test line region.

If the specimen contains SARS-CoV-2 Antigens, a colored line will appear in test line region as a result of this.

If the specimen does not contain antigens to SARS-CoV-2, no colored line will appear in the test line region, indicating a negative result. To serve as a procedural control, a colored line will always appear in the control line region, indicating that the proper volume of specimen has been added and membrane wicking has occurred.

The Influenza A+B Rapid Test (Nasopharyngeal Swab) is a qualitative, lateral flow immunoassay for the detection of Influenza A and Influenza B antigen in human nasopharyngeal swab specimen. In this test, antibody specific to the Influenza A and Influenza B is separately coated on the test line regions of the test. During testing, the extracted specimen reacts with the antibody to Influenza A and/or Influenza B that are coated onto particles.

The mixture migrates up the membrane to react with the antibody to Influenza A and/or Influenza B on the membrane and generate one or two colored lines in the test regions. The presence of this colored line in either or both of the test regions indicates a positive result.

To serve as a procedural control, a colored line will always appear in the control region if the test has performed properly.

 


† – “Due to Regulatory Restrictions, sales of these products may not be available in your territory. The SARS kits are CE/IVD in the EU”

Disclaimer: The information contained in this communication from the sender is confidential. It is intended solely for use by the recipient and others authorized to receive it. If you are not the intended recipient, you are hereby notified that any disclosure, copying, use, or distribution of the information included in this email is prohibited and may be unlawful.